These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 932933)

  • 1. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
    Dinovo EC; Gottschalk LA; Noble EP; Biener R
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.
    Chakraborty BS; Sardessai MS; Jaworski TJ; Midha KK; Hawes EM
    Pharm Res; 1987 Jun; 4(3):207-13. PubMed ID: 3509283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a metabolite of thioridazine and mesoridazine from human plasma.
    Gruenke LD; Craig JC
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):221-5. PubMed ID: 1162173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.
    Lin G; Hawes EM; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 1993 Oct; 23(10):1059-74. PubMed ID: 8259689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenolic metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL; Cowan DA
    Xenobiotica; 1985 Apr; 15(4):309-16. PubMed ID: 4024665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM; Mailman RB; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UVA-induced genetic effects of thioridazine, mesoridazine and sulforidazine: an in vitro study.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Panday IR
    Z Naturforsch C J Biosci; 1990 Jun; 45(6):638-44. PubMed ID: 2205215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):323-7. PubMed ID: 121276
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot of plasma thioridazine and metabolites in chronically treated patients.
    Papadopoulos AS; Chand TG; Crammer JL; Lader S
    Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
    Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
    J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers.
    Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT
    Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphoxide metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL
    Xenobiotica; 1986 Dec; 16(12):1097-107. PubMed ID: 3798957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
    Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
    Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin binding of thioridazine and some of its metabolites.
    Vandeheeren FA; Belpaire FM
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):86-91. PubMed ID: 1171660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.